MedPath
TGA Approval

XIFAXAN rifaximin 550 mg tablet blister pack (183411)

183411

XIFAXAN rifaximin 550 mg tablet blister pack

Norgine Pty Ltd

May 17, 2012

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-02283-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-PI-02052-3

Active Ingredients

rifaximin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

XIFAXAN rifaximin 550 mg tablet blister pack (183411) - TGA 批准文号 | MedPath